A 65-year-old woman diagnosed with breast carcinoma and treated with oral letrozole presented with diminution of vision in both eyes for 2 months. Best corrected visual acuity was 2/60 in the ...

Letrozole 2.5 mg produced a significantly higher overall objective response rate (24%) compared with MA (16%; logistic regression, P = .04) or letrozole 0.5 mg (13%; P = .004). Duration of objective ...

Letrozole is used to treat certain types of breast cancer. Find coupon and up to 80% savings options to help lower the cost of this medication.

Meanwhile, Dr. Gralow said, letrozole has some adverse effects, and the long-term effects that are associated with the drug still are being studied.

One hundred fourteen consecutive elderly women with T2-4 N0-1 and estrogen receptor–positive breast cancer were randomly assigned to primary letrozole therapy (2.5 mg daily for 6 months) or a ...

The drug letrozole, which suppresses estrogen production, cut the risk of breast cancer recurrence nearly in half for older women who had already taken the standard tamoxifen treatment ...

Overall, 228 women, or 87.4%, remained on letrozole therapy until the end of the six-month study. Only 25 (9.6%) of 261 women discontinued due to A/M and another 8 (3.1%) discontinued for other ...

Letrozole is a class of drug that blocks estrogen production. To compare the two drugs, researchers studied 750 infertile women with PCOS between 18 and 40 years old who wanted to conceive.

Women who received letrozole had more cumulative live births than those who received clomiphene (103 of 374 [27.5%] vs. 72 of 376 [19.1%], P=0.007; rate ratio for live birth, 1.44; 95% confidence ...

Cite this: Lidia Schapira. Neoadjuvant Palbociclib Plus Letrozole in ER-Positive Early Breast Cancer: PALLET Trial - Medscape - Mar 07, 2019.

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine, 2014; 371 (2): 119 DOI: 10.1056/NEJMoa1313517 ...